Heidelberg Pharma AG's market cap is currently ―. The company's EPS TTM is €-0.392; its P/E ratio is -7.62; Heidelberg Pharma AG is scheduled to report earnings on July 11, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Feb 23	Nov 22	Aug 22	May 22	Feb 22
Income Statement	-
Total Revenue	€ 2.07M	€ 2.82M	€ 3.76M	€ 11.22M	€ 715.73K
Gross Profit	€ 625.05K	€ 3.34M	€ 2.06M	€ 8.35M	€ 85.20K
EBIT	€ -6.18M	€ -6.21M	€ -4.38M	€ 736.48K	€ -7.08M
EBITDA	€ -5.96M	€ -6.03M	€ -4.20M	€ 926.55K	€ -6.88M
Net Income Common Stockholders	€ -6.56M	€ -6.48M	€ -4.62M	€ -1.36M	€ -7.25M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	€ 65.01M	€ 81.33M	€ 10.52M	€ 18.02M	€ 4.51M
Total Assets	€ 86.48M	€ 100.58M	€ 29.80M	€ 33.94M	€ 20.65M
Total Debt	€ 170.25K	€ 15.98M	€ 188.04K	€ 144.39K	€ 143.90K
Net Debt	€ -64.84M	€ -65.35M	€ -10.33M	€ -17.87M	€ -4.37M
Total Liabilities	€ 26.31M	€ 33.94M	€ 35.88M	€ 35.51M	€ 21.02M
Stockholders Equity	€ 60.16M	€ 66.64M	€ -6.07M	€ -1.58M	€ -364.66K
Cash Flow	-
Free Cash Flow	€ -11.06M	€ -7.98M	€ -8.41M	€ 13.54M	€ -6.62M
Operating Cash Flow	€ -10.74M	€ -7.66M	€ -8.26M	€ 13.59M	€ -6.52M
Investing Cash Flow	€ -301.66K	€ -316.00K	€ -146.79K	€ -50.80K	€ -83.97K
Financing Cash Flow	€ -5.03M	€ 79.07M	€ -20.74K	€ -24.25K	€ 4.98M

Currency in EUR

Heidelberg Pharma AG Earnings and Revenue History

Income Statement >

Heidelberg Pharma AG Debt to Assets

Balance Sheet >

Heidelberg Pharma AG Cash Flow

Cash Flow >

Heidelberg Pharma AG Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing